Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Hyon K. Choi, M.D.

Co-Author

This page shows the publications co-authored by Hyon Choi and Zachary Wallace.
Connection Strength

11.050
  1. ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry. J Rheumatol. 2021 07; 48(7):1060-1064.
    View in: PubMed
    Score: 0.943
  2. All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatology (Oxford). 2020 09 01; 59(9):2308-2315.
    View in: PubMed
    Score: 0.916
  3. Improving Mortality in End-Stage Renal Disease Due to Granulomatosis With Polyangiitis (Wegener's) From 1995 to 2014: Data From the United States Renal Data System. Arthritis Care Res (Hoboken). 2018 10; 70(10):1495-1500.
    View in: PubMed
    Score: 0.798
  4. Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System. Ann Rheum Dis. 2018 09; 77(9):1333-1338.
    View in: PubMed
    Score: 0.781
  5. Nationwide Trends in Hospitalizations and In-Hospital Mortality in Granulomatosis With Polyangiitis (Wegener's). Arthritis Care Res (Hoboken). 2017 06; 69(6):915-921.
    View in: PubMed
    Score: 0.727
  6. Improved survival in granulomatosis with polyangiitis: A general population-based study. Semin Arthritis Rheum. 2016 Feb; 45(4):483-9.
    View in: PubMed
    Score: 0.644
  7. The association of smoking with immunoglobulin G4-related disease: a case-control study. Rheumatology (Oxford). 2021 Nov 03; 60(11):5310-5317.
    View in: PubMed
    Score: 0.248
  8. Validation of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis as the Cause of End-Stage Renal Disease in the US Renal Data System. ACR Open Rheumatol. 2021 Oct 12.
    View in: PubMed
    Score: 0.247
  9. Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: An observational cohort study. Semin Arthritis Rheum. 2021 Sep 26; 51(6):1180-1185.
    View in: PubMed
    Score: 0.247
  10. Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic. ACR Open Rheumatol. 2021 Sep 08.
    View in: PubMed
    Score: 0.246
  11. Kidney Transplantation and Cardiovascular Events Among Patients with End-Stage Renal Disease due to Lupus Nephritis: A Nationwide Cohort Study. Arthritis Care Res (Hoboken). 2021 Jun 13.
    View in: PubMed
    Score: 0.242
  12. COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study. Arthritis Rheumatol. 2021 06; 73(6):914-920.
    View in: PubMed
    Score: 0.240
  13. Prolonged Increases in Public-Payer Spending and Prices After Unapproved Drug Initiative Approval of Colchicine. JAMA Intern Med. 2021 Feb 01; 181(2):284-287.
    View in: PubMed
    Score: 0.236
  14. Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study. Semin Arthritis Rheum. 2021 02; 51(1):150-157.
    View in: PubMed
    Score: 0.234
  15. Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study. Lancet Rheumatol. 2021 Feb; 3(2):e131-e137.
    View in: PubMed
    Score: 0.234
  16. Lifetime Allergy Symptoms in IgG4-Related Disease: A Case-Control Study. Arthritis Care Res (Hoboken). 2020 Dec 20.
    View in: PubMed
    Score: 0.234
  17. Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic. Ann Rheum Dis. 2021 05; 80(5):660-666.
    View in: PubMed
    Score: 0.233
  18. Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort Study. Arthritis Care Res (Hoboken). 2020 11; 72(11):1543-1549.
    View in: PubMed
    Score: 0.232
  19. Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. JAMA Intern Med. 2020 06 01; 180(6):870-876.
    View in: PubMed
    Score: 0.225
  20. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'. Ann Rheum Dis. 2020 09; 79(9):1156-1162.
    View in: PubMed
    Score: 0.225
  21. Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis. ACR Open Rheumatol. 2020 May; 2(5):261-268.
    View in: PubMed
    Score: 0.223
  22. Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race. Ann Allergy Asthma Immunol. 2020 08; 125(2):190-195.e2.
    View in: PubMed
    Score: 0.222
  23. Decomposition Analysis of Spending and Price Trends for Biologic Antirheumatic Drugs in Medicare and Medicaid. Arthritis Rheumatol. 2020 02; 72(2):234-241.
    View in: PubMed
    Score: 0.219
  24. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 01; 79(1):77-87.
    View in: PubMed
    Score: 0.217
  25. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020 01; 72(1):7-19.
    View in: PubMed
    Score: 0.217
  26. Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2019 11; 71(11):1879-1887.
    View in: PubMed
    Score: 0.214
  27. Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis. Ann Rheum Dis. 2020 04; 79(4):e40.
    View in: PubMed
    Score: 0.205
  28. Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study. Ann Intern Med. 2019 02 19; 170(4):240-247.
    View in: PubMed
    Score: 0.205
  29. All-Cause and Cause-Specific Mortality Trends of End-Stage Renal Disease Due to Lupus Nephritis From 1995 to 2014. Arthritis Rheumatol. 2019 03; 71(3):403-410.
    View in: PubMed
    Score: 0.204
  30. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 03; 78(3):406-412.
    View in: PubMed
    Score: 0.204
  31. An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index. Arthritis Care Res (Hoboken). 2018 11; 70(11):1671-1678.
    View in: PubMed
    Score: 0.202
  32. Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2017 07; 69(7):1004-1010.
    View in: PubMed
    Score: 0.184
  33. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016 09; 68(9):2283-9.
    View in: PubMed
    Score: 0.174
  34. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford). 2016 Jun; 55(6):1000-8.
    View in: PubMed
    Score: 0.167
  35. Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study. Lancet Rheumatol. 2021 Sep; 3(9):e638-e647.
    View in: PubMed
    Score: 0.060
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.